Utility of SPECT/CT in Non-Traumatic Osteonecrosis: Revisited with New Insights from a Prospective Diagnostic Study.

OBJECTIVES

Bone scintigraphy is a sensitive imaging method to evaluate patients with suspected osteonecrosis. We assessed the diagnostic performance of combined bone single-photon emission computed tomography/computed tomography (SPECT/CT) (CBS) in patients with known rheumatic disease or other connective tissue disorders and clinical suspicion of osteonecrosis compared to magnetic resonance imaging (MRI).

METHODS

This prospective diagnostic accuracy study included 70 patients with clinical suspicion of osteonecrosis in any bone who underwent a planar triple-phase bone scan along with a regional SPECT/CT (CBS) and regional MRI. MRI was considered the standard for diagnosing the sensitivity, specificity, predictive values, and accuracy of CBS. Cohen's kappa statistic of the agreement was also calculated.

RESULTS

The distribution of the patients based on the joint regions suspected to have osteonecrosis is as follows: 21 hip, 43 knee, and six ankle. MRI detected osteonecrosis in 30/70 patients. CBS had a sensitivity of 100% (30/70 were detected) and a specificity of 97% (2/40 were false positive). Overall, there was good agreement between the two scans regarding the diagnosis of osteonecrosis (Cohen's kappa statistic = 0.94). In addition to the suspected sites, CBS detected osteonecrosis in 19 additional asymptomatic sites in 13 patients.

CONCLUSION

The study has demonstrated that CBS, which includes whole-body imaging and SPECT/CT, is highly sensitive in detecting osteonecrosis with accuracy comparable to regional MRI. Its inherent whole-body imaging technique enabled the detection of multifocal osteonecrosis. It can be used as an early investigating modality after routine plain radiography to establish the diagnosis.